Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

11 June 1999

Perioperative Single High Dose ATG-Fresenius S Administration as Induction Immunosuppressive Therapy in Cadaveric Renal Transplantation- Preliminary Results

Radoslaw Samsel, Andrzej Chmura, Zbigniew Wlodarczyk, Janusz Wyzgal, Tomasz Cieciura, Jacek Pliszczynski, Grazyna Korczak, Tomasz Lazowski, Leszek Paczek, Janusz Walaszewski, Mieczyslaw Lao, Wojciech Rowinski

Ann Transplant 1999; 4(2): 37-39 :: ID: 497453

Abstract

Monoclonal and polyclonal antilymphocyte antibodies have been used successfully in organ transplantation as induction therapy and in the treatment of acute graft rejection. Used for induction the medication is generally given for the first 7-10 days. The aim of this study was to assess the safety and efficacy of single high dose (9 mg/kg) ATG Fresenius Sgiven perioperatively, before revascularization, to kidney allograft recipients. During last twelve months seventy six, first cadaveric kidney adult recipients were included into the study in two centers (center A-64, center 8-12). All patients received triple drug immunosuppression(Neoral. steroids and Cellcept which was replaced by azathioprine after 4 months). and were randomized to receive ATG or not. The follow-up period ranged from I month up to I year. The preliminary results are very promising. the rejection rate in bolus group was significantly lower than in control. No significant side effects or serious adverse events in both groups were observed.

Keywords: Atg, Kidney Transplantation, Immunosuppression, inductiontherapy

0 Comments

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358